Mainz Biomed Initiates Clinical Study to Evaluate Integrating Novel mRNA Biomarkers Into ColoAlert
Results to impact ColoAlert profile for FDA submission Provides opportunity for ColoAlert to achieve gold…
News
Arcellx Announces Pricing of Initial Public Offering
GAITHERSBURG, Md., Feb. 04, 2022 (GLOBE NEWSWIRE) — Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company…
Press Release: Strong 2021 sales and business EPS growth enabling increased investment in R&D
Strong 2021 sales and business EPS(1) growth enabling increased investment in R&D Paris, February 4,…
Press Release: Strong 2021 sales and business EPS growth enabling increased investment in R&D
Strong 2021 sales and business EPS(1) growth enabling increased investment in R&D Paris, February 4,…
HIVE Blockchain Provides January 2022 Production Update
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus…
Valneva and Pfizer Report Further Positive Phase 2 Data for Lyme Disease Vaccine Candidate
Dose selection complete for planned Phase 3 trial, expected to be initiated in 3Q2022 Sub-analysis…
Silver Spike Investment Corp. Prices Initial Public Offering
NEW YORK–(BUSINESS WIRE)–Silver Spike Investment Corp. (“SSIC”), a newly-organized closed-end management investment company that has…
CardioComm Solutions Completes Issuance of Shares for Debt
Toronto, Ontario–(Newsfile Corp. – February 3, 2022) – CardioComm Solutions, Inc. (TSXV: EKG) (“CardioComm” or…
The Arena Group Announces Uplist Date to NYSE American
NEW YORK–(BUSINESS WIRE)–theMaven, Inc. (OTCQX: MVEN), currently operating under the brand name The Arena Group…
Orchard Therapeutics Announces Historic Agreement Making Libmeldy Available by NHS England for MLD Patients
First-ever lentiviral hematopoietic stem cell gene therapy approved for reimbursement by NHS England Two children…
Monte Rosa Therapeutics Announces Participation in Upcoming Investor Conferences
BOSTON, Feb. 03, 2022 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a biotechnology…
PLx Pharma Inc. Proudly Celebrates Go Red for Women Day® 2022 to Support Heart Health Awareness
— Female-Led Company Strives to Transform Standard of Care in Secondary Prevention of Heart Attack or…
Arvinas to Present at Upcoming Investor Conferences
NEW HAVEN, Conn., Feb. 03, 2022 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage…
Algonaut Capital Corp. Completes Acquisition of Algodev, Inc, Enters into Term Sheet to Combine and Become Listed Issuer and Provides Update on Financing Activities
Calgary, Alberta–(Newsfile Corp. – February 3, 2022) – Algonaut Capital Corporation (“Algonaut” or the “Corporation“)…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Meta Platforms, Inc. (FB) on Behalf of Investors
Shareholders with $100,000 losses or more are encouraged to contact the firm. LOS ANGELES–(BUSINESS WIRE)–Glancy…
BGSF, Inc. Announces 29th Consecutive Quarterly Dividend
PLANO, Texas–(BUSINESS WIRE)–BGSF, Inc. (NYSE: BGSF), a leading national provider of workforce solutions, today announced…
Materion Corporation to Announce Fourth-quarter and Full-year 2021 Financial Results on Feb. 17
MAYFIELD HEIGHTS, Ohio–(BUSINESS WIRE)–Materion Corporation (NYSE: MTRN) is scheduled to release its fourth-quarter and full-year…
PowerSchool to Announce Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022
FOLSOM, Calif.–(BUSINESS WIRE)–PowerSchool Holdings, Inc. (NYSE: PWSC) (“PowerSchool” or the “Company”), the leading provider of…
Industrias Bachoco Announces Fourth Quarter and Full Year 2021 Results
CELAYA, Mexico–(BUSINESS WIRE)–Industrias Bachoco, S.A.B. de C.V., “Bachoco” or “the Company”, (NYSE: IBA; BMV: Bachoco)…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Roblox Corporation (RBLX) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…